Cargando…
PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
The optimal booster vaccine schedule against COVID-19 is still being explored. The present study aimed at assessment of the immunogenicity and antibody persistency of inactivated-virus based vaccine, BBIP-CorV and protein-subunit based vaccines, PastoCovac/Plus through heterologous and homologous pr...
Autores principales: | Ramezani, Amitis, Sorouri, Rahim, Haji Maghsoudi, Saiedeh, Dahmardeh, Sarah, Doroud, Delaram, Sadat Larijani, Mona, Eybpoosh, Sana, Mostafavi, Ehsan, Olyaeemanesh, Alireza, Salehi-Vaziri, Mostafa, Bavand, Anahita, Zarghani, Ghazaleh, Moradi, Ladan, Ashrafian, Fatemeh, Bagheri Amiri, Fahimeh, Mashayekhi, Parisa, Tahmasebi, Zahra, Biglari, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195798/ https://www.ncbi.nlm.nih.gov/pubmed/37202438 http://dx.doi.org/10.1038/s41598-023-35147-y |
Ejemplares similares
-
Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
por: Eybpoosh, Sana, et al.
Publicado: (2023) -
Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
por: Farahmand, Behrokh, et al.
Publicado: (2023) -
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
por: Barkhordar, Maryam, et al.
Publicado: (2023) -
Pasto verde
por: García Saldaña, Parménides
Publicado: (1968) -
Explotación de pastos
Publicado: (1979)